Here are five highlights:
1. In 2015, the market was valued at $24.31 billion.
2. The market is expected to hit $29.15 billion by 2020.
3. From 2015 to 2020, the market is anticipated to increase at a compound annual growth rate of 3.7 percent.
4. Increased regulation aimed at preventing hospital-acquired infections is spurring market growth.
5. Vendors include STERIS, Getinge Group, Stryker, Hill-Rom Holdings, Drägerwerk, GE Healthcare, Mizuho, Philips Healthcare, Medtronic and KARL STORZ.
More articles on quality & infection control:
HHS seeks $56.6M in poor patient care suit against Vanguard: 5 key notes
Spending on orphan drug spending often overestimated: 5 takeaways
EpiPen may be more of the same: A look into the underlying problem in the pharmaceutical industry
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.